Breakthrough CRISPR Gene Editing Trial Set to Begin This Year – Newsweek
Newsweek |
Breakthrough CRISPR Gene Editing Trial Set to Begin This Year
Newsweek Biotech company CRISPR Therapeutics is set to treat Europe's patients with the CRISPR gene-editing tool this year following regulatory approval for trials. Researchers will apply the much-hyped tool to patients with beta thalassaemia, an inherited … Synthetic Molecules Could Improve CRISPR Inventor, chemist, and CRISPR craftsman: Inside David Liu's evolution workshop |
